Given the angiostatic properties that were previously attributed to lumican within a tumor microenvironment15, particular attention was paid to the influence of host lumican deficiency on both tumor vascularization and response to a matrix-targeted anti-angiogenic approach. This evidence concerns the gene LUM and neoplasm.